Literature DB >> 17318180

The adaptor Grb7 links netrin-1 signaling to regulation of mRNA translation.

Nien-Pei Tsai1, Jing Bi, Li-Na Wei.   

Abstract

We previously reported a novel biological activity of Netrin-1 in translational stimulation of kappa opioid receptor (KOR). We now identify Grb7 as a new RNA-binding protein that serves as the molecular adaptor for transmitting Netrin-1 signals, through focal adhesion kinase (FAK), to the translation machinery. Grb7 binds specifically to the first stem loop of kor mRNA 5'-UTR through a new RNA-binding domain located in its amino terminus. Upon binding to its capped, target mRNA, Grb7 blocks the recruitment of eIF4E, rendering mRNA untranslatable. The RNA-binding and translation-repressive activity is reduced by FAK-mediated hyperphosphorylation on two tyrosine residues of its carboxyl terminus. This study reports an adaptor protein Grb7 that transmits the stimulating signals of Netrin-1 to the translational machinery to rapidly regulate mRNA translation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17318180      PMCID: PMC1829368          DOI: 10.1038/sj.emboj.7601598

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  33 in total

Review 1.  Regulation of opioid receptor expression.

Authors:  Li-Na Wei; Horace H Loh
Journal:  Curr Opin Pharmacol       Date:  2002-02       Impact factor: 5.547

2.  Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation.

Authors:  D S Campbell; C E Holt
Journal:  Neuron       Date:  2001-12-20       Impact factor: 17.173

3.  Apoptotic pathway and MAPKs differentially regulate chemotropic responses of retinal growth cones.

Authors:  Douglas S Campbell; Christine E Holt
Journal:  Neuron       Date:  2003-03-27       Impact factor: 17.173

4.  Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes.

Authors:  Vinagolu K Rajasekhar; Agnes Viale; Nicholas D Socci; Martin Wiedmann; Xiaoyi Hu; Eric C Holland
Journal:  Mol Cell       Date:  2003-10       Impact factor: 17.970

Review 5.  Multiple opiate receptors: déjà vu all over again.

Authors:  Gavril W Pasternak
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

6.  A novel role of the mammalian GSPT/eRF3 associating with poly(A)-binding protein in Cap/Poly(A)-dependent translation.

Authors:  Naoyuki Uchida; Shin-Ichi Hoshino; Hiroaki Imataka; Nahum Sonenberg; Toshiaki Katada
Journal:  J Biol Chem       Date:  2002-10-14       Impact factor: 5.157

7.  Netrin requires focal adhesion kinase and Src family kinases for axon outgrowth and attraction.

Authors:  Guofa Liu; Hilary Beggs; Claudia Jürgensen; Hwan-Tae Park; Hao Tang; Jessica Gorski; Kevin R Jones; Louis F Reichardt; Jane Wu; Yi Rao
Journal:  Nat Neurosci       Date:  2004-10-17       Impact factor: 24.884

8.  Focal adhesion kinase in netrin-1 signaling.

Authors:  Xiu-Rong Ren; Guo-Li Ming; Yi Xie; Yan Hong; Dong-Mei Sun; Zhong-Qiu Zhao; Zhu Feng; Qiang Wang; Sangwoo Shim; Zhou-Feng Chen; Hong-Jun Song; Lin Mei; Wen-Cheng Xiong
Journal:  Nat Neurosci       Date:  2004-10-17       Impact factor: 24.884

9.  Activation of FAK and Src are receptor-proximal events required for netrin signaling.

Authors:  Weiquan Li; Jeeyong Lee; Haris G Vikis; Seung-Hee Lee; Guofa Liu; Jennifer Aurandt; Tang-Long Shen; Eric R Fearon; Jun-Lin Guan; Min Han; Yi Rao; Kyonsoo Hong; Kun-Liang Guan
Journal:  Nat Neurosci       Date:  2004-10-17       Impact factor: 24.884

10.  Suppressive effect of receptor-interacting protein 140 on coregulator binding to retinoic acid receptor complexes, histone-modifying enzyme activity, and gene activation.

Authors:  Xinli Hu; Yixin Chen; Mariya Farooqui; Mary C Thomas; Cheng-Ming Chiang; Li-Na Wei
Journal:  J Biol Chem       Date:  2003-10-27       Impact factor: 5.157

View more
  31 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 2.  Transcriptional and epigenetic regulation of opioid receptor genes: present and future.

Authors:  Li-Na Wei; Horace H Loh
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011       Impact factor: 13.820

Review 3.  Local translation of mRNAs in neural development.

Authors:  Hosung Jung; Christine E Holt
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-10-19       Impact factor: 9.957

Review 4.  Local translation and directional steering in axons.

Authors:  Andrew C Lin; Christine E Holt
Journal:  EMBO J       Date:  2007-07-26       Impact factor: 11.598

5.  Copb1-facilitated axonal transport and translation of kappa opioid-receptor mRNA.

Authors:  Jing Bi; Nien-Pei Tsai; Hsin-Yi Lu; Horace H Loh; Li-Na Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-13       Impact factor: 11.205

6.  Dynein motor contributes to stress granule dynamics in primary neurons.

Authors:  N-P Tsai; Y-C Tsui; L-N Wei
Journal:  Neuroscience       Date:  2009-01-03       Impact factor: 3.590

7.  RNA-binding motif protein 35A is a novel tumor suppressor for colorectal cancer.

Authors:  Olga V Leontieva; Yuri Ionov
Journal:  Cell Cycle       Date:  2009-02-22       Impact factor: 4.534

8.  RhoA/ROCK1 signaling regulates stress granule formation and apoptosis.

Authors:  Nien-Pei Tsai; Li-Na Wei
Journal:  Cell Signal       Date:  2009-12-11       Impact factor: 4.315

9.  Specificity and sufficiency of EphB1 in driving the ipsilateral retinal projection.

Authors:  Timothy J Petros; Brikha R Shrestha; Carol Mason
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

10.  The cell migration protein Grb7 associates with transcriptional regulator FHL2 in a Grb7 phosphorylation-dependent manner.

Authors:  Sharareh Siamakpour-Reihani; Haroula J Argiros; Lori J Wilmeth; L Lowell Haas; Tabitha A Peterson; Dennis L Johnson; Charles Brad Shuster; Barbara A Lyons
Journal:  J Mol Recognit       Date:  2009 Jan-Feb       Impact factor: 2.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.